1-Benzyl-3-(5‘-hydroxymethyl-2‘-furyl)indazole (YC-1) Derivatives as Novel Inhibitors Against Sodium Nitroprusside-Induced Apoptosis-Reference-Cited by-同舟云学术

1-Benzyl-3-(5‘-hydroxymethyl-2‘-furyl)indazole (YC-1) Derivatives as Novel Inhibitors Against Sodium Nitroprusside-Induced Apoptosis

Published:2002-10-08 Issue:23 Volume:45 Page:4947-4949
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Lien Jin-Cherng¹,Lee Fang-Yu¹,Huang Li-Jiau¹,Pan Shiow-Lin¹,Guh Jih-Hwa¹,Teng Che-Ming¹,Kuo Sheng-Chu¹

Affiliation:

1. Graduate Institute of Pharmaceutical Chemistry, China Medical College, Taichung, Taiwan, Yung-Shin Pharmaceutical Industry Co., Ltd., Tachia, Taichung, Taiwan, and Pharmacological Institute, College of Medicine, National Taiwan University, Taiwan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm020070b

Reference19 articles.

1. ScienceScope

2. Septic Shock in Humans

3. The Effect of Glutathione andN-Acetylcysteine on Lipoperoxidative Damage in Patients with Early Septic Shock

4. An uncommon cause of lower limb weakness

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Scalable and Metal-Free Synthesis of Indazoles from 2-Aminophenones and In Situ Generated De-Boc-Protected O-Mesitylsulfonyl Hydroxylamine Derivatives;The Journal of Organic Chemistry;2023-08-30

2. Synthesis of Substituted Indazole Acetic Acids by N−N Bond Forming Reactions;European Journal of Organic Chemistry;2023-05-24

3. Aerobic Cu(I)‐Catalyzed Site‐Selective 1,3‐Difunctionalization of Indazole through Cascade C−N and C−O Bond Formation;Advanced Synthesis & Catalysis;2023-01-31

4. A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective;Drug Development Research;2022-08-16

5. Synthetic strategy and structure–activity relationship (SAR) studies of 3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole (YC-1, Lificiguat): a review;RSC Advances;2022